Molecule of the month. Mircera and Daronrix.
D000740:Anemia / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype / Q000276:immunology; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000517:prevention & control; D007674:Kidney Diseases / Q000188:drug therapy*; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins
D007252:Influenza Vaccines; D011994:Recombinant Proteins; C508420:continuous erythropoietin receptor activator; D004921:Erythropoietin; D011092:Polyethylene Glycols